Please wait while the formulary information is being retrieved.
ONDANSETRON HCL-0.9% NACL (ONDANSETRON HCL IN 0.9 % SODIUM CHLORIDE)
ondansetron 16 mg/100 mL in 0.9% sodium chloride intravenous piggyback
- Dosage information is not available
ondansetron 16 mg/50 mL in 0.9 % sodium chloride intravenous piggyback
- Dosage information is not available
ondansetron 8 mg/50 mL in 0.9 % sodium chloride intravenous piggyback
- Dosage information is not available
- Apokyn
- apomorphine
Contraindicated
- amiodarone
- amiodarone in dextrose,iso-osm
- artemether-lumefantrine
- Coartem
- Cordarone
- disopyramide
- dronedarone
- droperidol
- Geodon
- Multaq
- Nexterone
- Norpace
- Norpace Cr
- Orap
- Pacerone
- pimozide
- ziprasidone HCl
- ziprasidone mesylate
Severe
Moderate
- Ablavar
- Advair Diskus
- Advair Hfa
- alfuzosin
- amantadine HCl
- Anzemet
- Astagraf Xl
- azithromycin
- bedaquiline
- Cardene Iv
- Cardene Iv In Dextrose
- Cardene Iv In Sodium Chloride
- Cardene Sr
- chloroquine phosphate
- chlorpromazine
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- clozapine
- Clozaril
- Complera
- Conzip
- Corvert
- crizotinib
- dasatinib
- dolasetron
- Edurant
- Effexor Xr
- emtricitab-rilpivirine-tenofov
- eribulin
- ezogabine
- Fareston
- Fazaclo
- felbamate
- Felbatol
- flecainide
- fluticasone-salmeterol
- foscarnet
- Foscavir
- gadofosveset trisodium
- granisetron
- granisetron (PF)
- Granisol
- Halaven
- Hecoria
- ibutilide fumarate
- indapamide
- Invega
- Invega Sustenna
- Invirase
- isradipine
- Istodax
- Kaletra
- lapatinib
- Levitra
- lithium carbonate
- lithium citrate
- Lithobid
- lopinavir-ritonavir
- moexipril
- moexipril-hydrochlorothiazide
- Nebupent
- Nexavar
- nicardipine
- nicardipine in dextrose,iso-os
- nicardipine in NaCl (iso-os)
- nilotinib
- norfloxacin
- Noroxin
- Noxafil
- octreotide acetate
- ofloxacin
- paliperidone
- paliperidone palmitate
- pasireotide
- pazopanib
- Pentam
- pentamidine
- posaconazole
- Potiga
- procainamide
- Prograf
- propafenone
- Qualaquin
- quetiapine
- quinine sulfate
- rilpivirine
- romidepsin
- Rythmol
- salmeterol
- Sancuso
- Sandostatin
- Sandostatin Lar Depot
- saquinavir mesylate
- Serevent Diskus
- Seroquel
- Seroquel Xr
- Signifor
- Sirturo
- Soltamox
- sorafenib
- Sprycel
- sunitinib
- Sutent
- Synapryn
- tacrolimus
- tamoxifen
- Tasigna
- telavancin
- tetrabenazine
- tizanidine
- toremifene
- tramadol
- tramadol-acetaminophen
- tramadol-glucosamine
- Tykerb
- Ultracet
- Ultram
- Ultram Er
- Uniretic
- Univasc
- Uroxatral
- vardenafil
- vemurafenib
- venlafaxine
- Versacloz
- Vfend
- Vfend Iv
- Vibativ
- voriconazole
- Votrient
- Xalkori
- Xenazine
- Zanaflex
- Zelboraf
- Zithromax
- Zithromax Tri-pak
- Zithromax Z-pak
- Zmax
- Congenital long QT syndrome
- Prolonged QT interval
- Torsades de pointes
Contraindicated
- Hypocalcemia
- Hypokalemia
- Hypomagnesemia
- Neuroleptic malignant syndrome
- Serotonin syndrome
- Severe hepatic disease
Severe
Moderate
- Bradycardia
- Chronic heart failure
- Extrapyramidal disease
- Seizure disorder
ONDANSETRON HCL-0.9% NACL (ONDANSETRON HCL IN 0.9 % SODIUM CHLORIDE)
- None
- Chills
- Constipation
- Diarrhea
- Fever
- Headache disorder
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Dizziness
- Drowsy
- Paresthesia
- Pruritus of skin
- Sensation of cold
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal ECG
- Abnormal hepatic function tests
- Acquired dystonia
- Acute hepatic failure
- Anaphylaxis
- Angina
- Angioedema
- Atrial fibrillation
- Blurred vision
- Bradycardia
- Bronchospastic pulmonary disease
- Dyspnea
- Extrapyramidal disease
- Hypersensitivity drug reaction
- Hypotension
- Injection site sequelae
- Laryngeal edema
- Prolonged QT interval
- Second degree atrioventricular heart block
- Serotonin syndrome
- Shock
- ST segment changes
- Stevens-johnson syndrome
- Syncope
- Torsades de pointes
- Toxic epidermal necrolysis
- Transient blindness
- Ventricular premature beats
Less Severe
- Arthralgias
- Chest discomfort
- Flushing
- Hiccups
- Hyperhidrosis
- Lethargy
- Palpitations
- Purpura
- Skin rash
- Tachycardia
- Urticaria
Contraindicated
None
Severe Precaution
Ondansetron (Select routes)
Limited information age < 30 days. Longer half-life in infants. Monitor closely.
Longer half-life in age < 4 months. Monitor closely.
- 1 Day – 29 Days
- Limited information age < 30 days. Longer half-life in infants. Monitor closely.
- Longer half-life in age < 4 months. Monitor closely.
- 30 Days – 119 Days
- Limited information age < 30 days. Longer half-life in infants. Monitor closely.
- Longer half-life in age < 4 months. Monitor closely.
Management or Monitoring Precaution
None
Ondansetron
- Severity Level:
2
- Additional Notes: Insufficient human data available; no developmental toxicity seen in animals
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ondansetron
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Ondansetron
Cardiovascular-The elderly are more prone to QT prolongation due to multiple meds and iatrogenic hypokalemia, hypomagnesemia; correct electrolytes before giving oral or IV ondansetron. Neuro/Psych-The elderly may be more prone to extrapyramidal reactions associated with IV doses.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
Formulary Reference Tool